Camlin Fine (CAMLINFINE)
TurnaroundFairStock Score: 26/100 — RISKY
Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1
Key Financials
| Current Price | ₹103.76 |
| Market Cap | ₹1,993.14 Cr |
| P/E Ratio | 1,000 |
| ROCE | 11.03% |
| ROE | -1.86% |
| Dividend Yield | 0% |
| Profit Growth | -196.04% |
| Debt/Equity | 0.72 |
| Sales Growth | 166.43% |
| Promoter Holding | 48.03% |
| 52-Week Range | ₹96.21 — ₹235 |
| Sector | Chemicals & Petrochemicals |
| Book Value | ₹54.19 |
Strengths
- Promoter holding of 48.03% keeps owner interests aligned.
- Latest quarter sales of ₹457 Cr shows meaningful business scale.
- ROCE of 11.03% indicates some positive operating capital efficiency despite the net loss.
- Debt/equity of 0.78 is not extreme, providing some balance sheet buffer.
- Sales growth remains positive at 6.07%.
Concerns
- Latest quarter net loss of ₹37 Cr and profit growth of -1607.76% show severe earnings deterioration.
- P/E of 1000 and PEG of 164.74 make valuation disconnected from underlying profitability.
- Negative ROE of -1.86% and zero dividend yield mean shareholders are getting no return.
- Piotroski F-score of 4/9 and P/B of 3.67 offer poor financial health signals and no valuation cushion.
AI Analysis
To be honest, Camlin Fine does not look like a business I would put into my wallet. At ₹120.73, the market is asking me to pay ₹2,841 Cr for a company whose latest quarter delivered ₹457 Cr of sales but a net loss of ₹37 Cr. Profit growth is -1607.76% and return on equity is -1.86%. This is not the sort of earning power I need. The P/E of 1000 means little when profits have collapsed; P/B of 3.67 is steep against book value of ₹32.88. I can find no margin of safety. Sales growth is only 6.07%, and dividend yield is zero, so I am not being paid to wait. The only encouraging figures are ROCE of 11.03% and a moderate debt/equity of 0.78, but the Piotroski F-score of 4/9 and the huge negative profit trend tell me something is wrong. A promoter holding of 48.03% is fine, but good ownership cannot rescue poor economics. The price has fallen from a 52-week high of ₹235 to ₹120.73, yet a fall in price alone does not make it cheap. This looks like a turnaround situation, but the evidence is not with the optimists—net loss, negative ROE, no dividend, and a FairStock Score of 10/100. If the company must continue borrowing or burning capital to operate, debt could become a heavier burden. I prefer businesses with stable earnings, a durable moat, and honest growth. Camlin Fine fails those tests today. I will watch from the sidelines until the financials, not the narrative, demonstrate a genuine and sustainable recovery. In investing, the most important thing is survival; this stock lacks the quality for me to risk capital.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer